Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  USANA Health Sciences, Inc.    USNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Khang & Khang LLP Announces Securities Class Action Lawsuit against USANA Health Sciences, Inc., and Encourages Investors with Losses to Contact the Firm

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2017 | 07:56pm CET

IRVINE, CA / ACCESSWIRE / February 22, 2017 /Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against USANA Health Sciences, Inc. ("USANA" or the "Company") (NYSE: USNA) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired shares between March 14, 2014 and February 7, 2017 inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the April 14, 2017 lead plaintiff motion deadline.

If you purchased shares of USANA during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

USANA develops, manufactures, and sells nutritional and personal care products primarily to reduce the risk of chronic degenerative disease.

On February 7, 2017, USANA revealed that it will be starting an internal investigation of its Chinese subsidiary, BabyCare Ltd. ("BabyCare").

In particular, the Company's investigation concerns "compliance with the Foreign Corrupt Practices Act," as well as "BabyCare's expense reimbursement policies."

When this information was revealed to the investing public, the value of USANA declined, causing investors harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 joon@khanglaw.com

SOURCE: Khang & Khang LLP

Copyright © 2017 accesswire. All Rights Reserved., source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on USANA HEALTH SCIENCES, INC
07:56p Khang & Khang LLP Announces Securities Class Action Lawsuit against USANA Hea..
07:56p USANA HEALTH SCIENCES, INC. : Khang & Khang LLP Announces Securities Class Actio..
02/21 USANA HEALTH SCIENCES, INC. : INVESTOR NOTICE: Lundin Law PC Announces Securitie..
02/20 USANA HEALTH SCIENCES : ' China Subsidiary, BabyCare Ltd., Becomes an Official S..
02/19 JOHNSON & WEAVER, LLP : Announces Investigations of Clovis Oncology, Inc., USANA..
02/17 USANA HEALTH SCIENCES, INC. : Khang & Khang LLP Announces Securities Class Actio..
02/17 ROBBINS ARROYO LLP : USANA Health Sciences, Inc. (USNA) Misled Shareholders Acco..
02/16 Goldberg Law PC Announces Securities Class Action Lawsuit against USANA Healt..
02/16 Lundin Law PC Announces Securities Class Action Lawsuit against USANA Health ..
02/15 USANA HEALTH SCIENCES : The Law Offices of Howard G. Smith Announces the Filing ..
More news
Sector news : Personal Products - NEC
06:22p Unilever, Lloyds help FTSE edge higher
04:03pDJUnilever Launches Review After Rejecting Kraft Heinz Offer--2nd Update
03:50pDJUnilever Launches Review After Rejecting Kraft Heinz Offer--Update
03:29pDJCorrection to Unilever Launches Strategic Review story
03:08pDJUnilever Launches Strategic Review After Rejecting Kraft Heinz Deal
More sector news : Personal Products - NEC
News from SeekingAlpha
02/08 USANA Health Sciences' (USNA) CEO David Wentz on Q4 2016 Results - Earnings C..
02/07 USANA Health Q4 sales up 9%; earnings off 9%; shares down 21% after hours on ..
02/07 After Hours Gainers / Losers
02/07 USANA Health Sciences misses by $0.07, misses on revenue
02/06 Notable earnings after Tuesday?s close
Advertisement
Financials ($)
Sales 2017 1 063 M
EBIT 2017 146 M
Net income 2017 97,2 M
Finance 2017 256 M
Yield 2017 -
P/E ratio 2017 15,12
P/E ratio 2018 12,90
EV / Sales 2017 1,12x
EV / Sales 2018 0,94x
Capitalization 1 447 M
More Financials
Chart USANA HEALTH SCIENCES, INC
Duration : Period :
USANA Health Sciences, Inc Technical Analysis Chart | USNA | US90328M1071 | 4-Traders
Full-screen chart
Technical analysis trends USANA HEALTH SCIE...
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 71,3 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin G. Guest Chief Executive Officer
Jim Brown President & Chief Operating Officer
Myron W. Wentz Chairman
Paul A. Jones CFO, CAO & Chief Leadership Development Officer
Kevin Spelman Executive Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
USANA HEALTH SCIENCES,..-3.02%1 447
PROCTER & GAMBLE CO9.03%234 352
UNILEVER14.53%133 968
UNILEVER PLC8.93%133 968
COLGATE-PALMOLIVE COMP..11.83%65 046
ESTEE LAUDER COMPANIES..10.66%31 013
More Results